SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-112919
Filing Date
2015-03-31
Accepted
2015-03-31 07:17:00
Documents
3
Period of Report
2015-03-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d898585d8k.htm 8-K 15099
2 EX-99.1 d898585dex991.htm EX-99.1 17058
3 GRAPHIC g898585ex99_1logo.jpg GRAPHIC 4433
  Complete submission text file 0001193125-15-112919.txt   39832
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 15736411
SIC: 3841 Surgical & Medical Instruments & Apparatus